Duality Advisers, LP Cytokinetics Inc Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 27, 2023
BUY
$33.36 - $45.71 $883,005 - $1.21 Million
26,469 New
26,469 $931,000
Q3 2022

Nov 03, 2022
BUY
$38.54 - $54.52 $998,494 - $1.41 Million
25,908 Added 83.23%
57,037 $2.76 Million
Q2 2022

Aug 08, 2022
BUY
$33.93 - $48.92 $1.06 Million - $1.52 Million
31,129 New
31,129 $1.22 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email